|
FAM98A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.77025061276481E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.64201985342061E-13 |
| Normal-vs-Stage2 |
4.014100E-04 |
| Normal-vs-Stage3 |
7.26160243047502E-11 |
| Normal-vs-Stage4 |
1.80955250783654E-12 |
| Stage1-vs-Stage2 |
1.688230E-01 |
| Stage1-vs-Stage3 |
6.094200E-01 |
| Stage1-vs-Stage4 |
2.791700E-02 |
| Stage2-vs-Stage3 |
9.483900E-02 |
| Stage2-vs-Stage4 |
8.324300E-03 |
| Stage3-vs-Stage4 |
1.199360E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.17603712826531E-14 |
| Normal-vs-AfricanAmerican |
9.99609999999818E-05 |
| Normal-vs-Asian |
9.15739706286445E-11 |
| Caucasian-vs-AfricanAmerican |
4.912200E-01 |
| Caucasian-vs-Asian |
5.320600E-01 |
| AfricanAmerican-vs-Asian |
3.739200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.81939957228417E-10 |
| Normal-vs-Female |
1.74371628247627E-12 |
| Male-vs-Female |
7.690000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.66056057793185E-12 |
| Normal-vs-Age(41-60Yrs) |
2.03770333939701E-11 |
| Normal-vs-Age(61-80Yrs) |
9.18370002267466E-09 |
| Normal-vs-Age(81-100Yrs) |
5.974000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.297200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.196600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.653600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.243600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.507820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.738400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.220800E-01 |
| Classical-VS-Follicular |
5.331600E-02 |
| Classical-VS-Other |
9.897600E-01 |
| Classical-VS-Normal |
1.63502544836547E-12 |
| Tall-VS-Follicular |
1.554490E-02 |
| Tall-VS-Other |
7.105000E-01 |
| Tall-VS-Normal |
1.05539998962456E-09 |
| Follicular-VS-Other |
5.458400E-01 |
| Follicular-VS-Normal |
4.1745000000093E-06 |
| Other-VS-Normal |
6.797900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.60730351040206E-11 |
| Normal-vs-N1 |
6.12843109593086E-14 |
| N0-vs-N1 |
1.157700E-02 |
|
|
